Literature DB >> 16914117

Identification of derlin-1 as a novel growth factor-responsive endothelial antigen by suppression subtractive hybridization.

Yuliang Ran1, Yangfu Jiang, Xing Zhong, Zhuan Zhou, Haiyan Liu, Hai Hu, Jin-Ning Lou, Zhihua Yang.   

Abstract

Endothelial cells play an important regulatory role in embryonic development, reproductive functions, tumor growth and progression. In the present study, the suppression subtractive hybridization (SSH) method was employed to identify differentially expressed genes between non-stimulated endothelial cells and activated endothelial cells. Following mRNA isolation of non-stimulated and hepatocellular carcinoma homogenate-stimulated cells, cDNAs of both populations were prepared and subtracted by suppressive PCR. Sequencing of the enriched cDNAs identified a couple of genes differentially expressed, including derlin-1. Derlin-1 was significantly up-regulated by tumor homogenates, VEGF, and endothelial growth supplements in a dose-dependent manner. Knock-down of derlin-1 triggered endothelial cell apoptosis, inhibited endothelial cell proliferation, and blocked the formation of a network of tubular-like structures. Our data reveal that derlin-1 is a novel growth factor-responsive endothelial antigen that promotes endothelial cell survival and growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914117     DOI: 10.1016/j.bbrc.2006.07.186

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Derlin-1 is overexpressed in human colon cancer and promotes cancer cell proliferation.

Authors:  Xueming Tan; Xiaolu He; Zhonghua Jiang; Xiaohong Wang; Limei Ma; Li Liu; Xiang Wang; Zhining Fan; Dongming Su
Journal:  Mol Cell Biochem       Date:  2015-07-15       Impact factor: 3.396

Review 2.  Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines.

Authors:  Michael W Graner; Kevin O Lillehei; Emmanuel Katsanis
Journal:  Front Oncol       Date:  2015-01-06       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.